Investor · New York, NY
Cory Freedland
Open Cory in the network graph →Capital
$170.1M
across filings
Active
Feb 2019
to Aug 2024
Most-connected co-filers (59)
Srinivas Akkaraju · SOUTH SAN FRANCISCO, CA3 sharedStephen M. Biggar · New York, NY2 sharedMani Subramanian · Palo Alto, CA2 sharedGangadhara Ganapati · PALO ALTO, CA2 sharedScott Morenstein · New York, NY2 sharedMuzammil B. Mansuri · New York, NY2 sharedMatthew Young · Chicago, IL2 sharedRachel Mcminn · New York, NY2 sharedEdward Fleming · Palo Alto, CA2 sharedAntonios T. Valamontes · Largo, FL1 sharedMatthew Ross · New York, NY1 sharedChristine M. Cvijic · Palo Alto, CA1 sharedDavid Edwards · Lexington, MA1 sharedBrandon Alexander · San Carlos, CA1 sharedStephen Tullman · Malvern, PA1 sharedGeorge H. Jenkins · Wayne, PA1 sharedKathleen S. Goin · Wayne, PA1 sharedTodd H. Davis · Wayne, PA1 sharedPaul Grayson · La Jolla, CA1 sharedKerrie H. Brady · Boston, MA1 sharedWilliam H. Koster · Boston, MA1 sharedDavid Krane · Mountain View, CA1 sharedWilliam B. Bissett · Charlotte, NC1 sharedKathleen S. Mcgowan · Wayne, PA1 shared Recent filings (8)
OrsoBio, Inc.Aug 2024 · 15 co-filers$67.0MOrsoBio, Inc.Aug 2024 · 15 co-filers$67.0MOrsoBio, Inc.Nov 2023 · 13 co-filers$84.6MOrsoBio, Inc.Nov 2023 · 13 co-filers$84.6MNeurogene Inc.Dec 2020 · 13 co-filers$115.0MNeurogene Inc.Dec 2020 · 13 co-filers$115.0MTentarix Biotherapeutics, LPSep 2020 · 11 co-filers$50.0MTentarix Biotherapeutics, LPSep 2020 · 11 co-filers$50.0MPalvella Therapeutics, Inc.Jun 2020 · 27 co-filers$45.0MPalvella Therapeutics, Inc.Jun 2020 · 27 co-filers$45.0MVelicept Therapeutics, Inc.Nov 2019 · 15 co-filers$9.2MVelicept Therapeutics, Inc.Nov 2019 · 15 co-filers$9.2MNeurogene Inc.Feb 2019 · 5 co-filers$37.5MNeurogene Inc.Feb 2019 · 5 co-filers$37.5MBioClin Therapeutics, Inc.Mar 2017 · 19 co-filers$30.0MBioClin Therapeutics, Inc.Mar 2017 · 19 co-filers$30.0M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Cory in the interactive graph →